Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001029142-24-000012
Filing Date
2024-11-07
Accepted
2024-11-07 16:18:30
Documents
78
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q dvax-20240930.htm   iXBRL 10-Q 1653812
2 EX-31.1 dvax-20240930xex311.htm EX-31.1 10512
3 EX-31.2 dvax-20240930xex312.htm EX-31.2 10854
4 EX-32.1 dvax-20240930xex321.htm EX-32.1 6204
5 EX-32.2 dvax-20240930xex322.htm EX-32.2 6188
  Complete submission text file 0001029142-24-000012.txt   8376937

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT dvax-20240930.xsd EX-101.SCH 62496
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT dvax-20240930_cal.xml EX-101.CAL 78346
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT dvax-20240930_def.xml EX-101.DEF 273841
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT dvax-20240930_lab.xml EX-101.LAB 749930
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT dvax-20240930_pre.xml EX-101.PRE 505109
81 EXTRACTED XBRL INSTANCE DOCUMENT dvax-20240930_htm.xml XML 1192669
Mailing Address 2100 POWELL STREET SUITE 720 EMERYVILLE CA 94608
Business Address 2100 POWELL STREET SUITE 720 EMERYVILLE CA 94608 5108485100
DYNAVAX TECHNOLOGIES CORP (Filer) CIK: 0001029142 (see all company filings)

EIN.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34207 | Film No.: 241436089
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)